Femasys (FEMY) to Release Quarterly Earnings on Thursday

Femasys (NASDAQ:FEMY) is anticipated to issue its quarterly earnings data before the market opens on Thursday, March 27th. Analysts expect the company to announce earnings of ($0.25) per share for the quarter.

Femasys Price Performance

NASDAQ FEMY opened at $1.60 on Wednesday. The company has a 50 day simple moving average of $1.39 and a 200-day simple moving average of $1.22. Femasys has a 52-week low of $0.86 and a 52-week high of $1.84. The firm has a market capitalization of $36.64 million, a price-to-earnings ratio of -1.98 and a beta of -2.85. The company has a debt-to-equity ratio of 0.86, a current ratio of 3.94 and a quick ratio of 3.26.

Analyst Ratings Changes

Separately, HC Wainwright raised their price target on shares of Femasys from $12.00 to $15.00 and gave the company a “buy” rating in a report on Wednesday, March 19th.

Femasys Company Profile

Femasys Inc, a biomedical company, develops therapeutic and diagnostic solutions to address unmet women healthcare needs worldwide. The company provides FemVue saline-air device, a contrast-generating product in the United States, Canada, Japan, and Hong Kong; FemCath, a cornual balloon catheter, a single intrauterine directional delivery product that allows for selective evaluation of an individual fallopian tube; and FemCerv, a biopsy device for endocervical curettage, which can be used to sample cervical cells and tissue circumferentially with sample containment within the device to minimize contamination.